Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.
Stahl M, Roehmel J, Eichinger M, Doellinger F, Naehrlich L, Kopp MV, Dittrich AM, Lee C, Sommerburg O, Tian S, Xu T, Wu P, Joshi A, Ray P, Duncan ME, Wielpütz MO, Mall MA. Stahl M, et al. Among authors: wielputz mo. Ann Am Thorac Soc. 2023 Aug;20(8):1144-1155. doi: 10.1513/AnnalsATS.202208-684OC. Ann Am Thorac Soc. 2023. PMID: 36943405 Free PMC article. Clinical Trial.
Magnetic resonance imaging-based scoring of the diseased lung in the preterm infant with bronchopulmonary dysplasia: UNiforme Scoring of the disEAsed Lung in BPD (UNSEAL BPD).
Förster K, Marchi H, Stöcklein S, Dietrich O, Ehrhardt H, Wielpütz MO, Flemmer AW, Schubert B, Mall MA, Ertl-Wagner B, Hilgendorff A. Förster K, et al. Among authors: wielputz mo. Am J Physiol Lung Cell Mol Physiol. 2023 Feb 1;324(2):L114-L122. doi: 10.1152/ajplung.00430.2021. Epub 2022 Nov 21. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36410026 Free article.
Implementation and evaluation of ultra-low dose CT in early cystic fibrosis lung disease.
Bayfield KJ, Weinheimer O, Boyton C, Fitzpatrick R, Middleton A, Kennedy B, Blaxland A, Jayasuriya G, Caplain N, Issa H, Goetti R, Wielpütz MO, Yu L, Galban CJ, Robinson TE, Bartholmai B, Fitzgerald D, Selvadurai H, Robinson PD. Bayfield KJ, et al. Among authors: wielputz mo. Eur Respir J. 2023 Jul 7;62(1):2300286. doi: 10.1183/13993003.00286-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37385656 Free PMC article.
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study.
Dettmer S, Weinheimer O, Sauer-Heilborn A, Lammers O, Wielpütz MO, Fuge J, Welte T, Wacker F, Ringshausen FC. Dettmer S, et al. Among authors: wielputz mo. Front Pharmacol. 2023 Sep 21;14:1245885. doi: 10.3389/fphar.2023.1245885. eCollection 2023. Front Pharmacol. 2023. PMID: 37808186 Free PMC article.
Morphologic and functional scoring of cystic fibrosis lung disease using MRI.
Eichinger M, Optazaite DE, Kopp-Schneider A, Hintze C, Biederer J, Niemann A, Mall MA, Wielpütz MO, Kauczor HU, Puderbach M. Eichinger M, et al. Among authors: wielputz mo. Eur J Radiol. 2012 Jun;81(6):1321-9. doi: 10.1016/j.ejrad.2011.02.045. Epub 2011 Mar 23. Eur J Radiol. 2012. PMID: 21429685
149 results